Whole-Exome Sequencing Reveals Defective <i>CYP3A4</i> Variants Predictive of Paclitaxel Dose-Limiting NeuropathyMaría Apellániz-Ruiz, Cristina Rodríguez‐Antona, Miyoung Lee et al.|Clinical Cancer Research|2014Cited by 72
Concomitant Medications and Risk of Chemotherapy-Induced Peripheral NeuropathyLara M. Munín Sánchez, Cristina Rodríguez‐Antona, María Apellániz-Ruiz et al.|The Oncologist|2018Cited by 37
A Combined Strategy of SAGE and Quantitative PCR Provides a 13-Gene Signature that Predicts Preoperative Chemoradiotherapy Response and Outcome in Rectal CancerE. Casado, Paloma Cejas, Víctor Moreno et al.|Clinical Cancer Research|2011Cited by 32
Upregulation of Trefoil Factor 3 (TFF3) After Rectal Cancer Chemoradiotherapy Is an Adverse Prognostic Factor and a Potential Therapeutic TargetEnrique Casado, Paloma Cejas, María Teresa Gómez del Pulgar et al.|International Journal of Radiation Oncology*Biology*Physics|2012Cited by 23
Targeted Sequencing Reveals Low-Frequency Variants in <i>EPHA</i> Genes as Markers of Paclitaxel-Induced Peripheral NeuropathyMaría Apellániz-Ruiz, Cristina Rodríguez‐Antona, Héctor Tejero et al.|Clinical Cancer Research|2016Cited by 22